date: 2022-12-03T02:45:53Z
pdf:PDFVersion: 1.4
pdf:docinfo:title: Is plasma amyloid-? 1?42/1?40 a better biomarker for Alzheimer?s disease than A?X?42/X?40?
xmp:CreatorTool: Springer
access_permission:can_print_degraded: true
subject: Fluids and Barriers of the CNS, https://doi.org/10.1186/s12987-022-00390-4
pdfa:PDFVersion: A-2b
xmpMM:History:Action: converted
language: EN
dc:format: application/pdf; version=1.4
pdf:docinfo:custom:robots: noindex
pdf:docinfo:creator_tool: Springer
access_permission:fill_in_form: true
xmpMM:History:When: 2022-12-02T20:46:22Z
pdf:encrypted: false
dc:title: Is plasma amyloid-? 1?42/1?40 a better biomarker for Alzheimer?s disease than A?X?42/X?40?
modified: 2022-12-03T02:45:53Z
cp:subject: Fluids and Barriers of the CNS, https://doi.org/10.1186/s12987-022-00390-4
xmpMM:History:SoftwareAgent: pdfToolbox
pdf:docinfo:custom:CrossMarkDomains[1]: springer.com
robots: noindex
pdf:docinfo:subject: Fluids and Barriers of the CNS, https://doi.org/10.1186/s12987-022-00390-4
xmpMM:History:InstanceID: uuid:1eacecf0-500b-454b-8ff3-ff67213be5e9
pdf:docinfo:creator: Hans-Wolfgang Klafki 
meta:author: Barbara Morgado 
meta:creation-date: 2022-12-02T15:14:03Z
pdf:docinfo:custom:CrossmarkMajorVersionDate: 2010-04-23
created: 2022-12-02T15:14:03Z
access_permission:extract_for_accessibility: true
Creation-Date: 2022-12-02T15:14:03Z
pdfaid:part: 2
pdf:docinfo:custom:CrossMarkDomains[2]: springerlink.com
pdf:docinfo:custom:doi: 10.1186/s12987-022-00390-4
pdf:docinfo:custom:CrossmarkDomainExclusive: true
Author: Barbara Morgado 
producer: Acrobat Distiller 10.1.8 (Windows); modified using iText® 5.3.5 ©2000-2012 1T3XT BVBA (SPRINGER SBM; licensed version)
CrossmarkDomainExclusive: true
pdf:docinfo:producer: Acrobat Distiller 10.1.8 (Windows); modified using iText® 5.3.5 ©2000-2012 1T3XT BVBA (SPRINGER SBM; licensed version)
doi: 10.1186/s12987-022-00390-4
pdf:unmappedUnicodeCharsPerPage: 0
dc:description: Fluids and Barriers of the CNS, https://doi.org/10.1186/s12987-022-00390-4
Keywords: Alzheimer?s disease; Biomarker; Amyloid-? peptides; Blood plasma; A?42/40 ratio; Immunoassay
access_permission:modify_annotations: true
dc:creator: Barbara Morgado 
description: Fluids and Barriers of the CNS, https://doi.org/10.1186/s12987-022-00390-4
dcterms:created: 2022-12-02T15:14:03Z
Last-Modified: 2022-12-03T02:45:53Z
dcterms:modified: 2022-12-03T02:45:53Z
title: Is plasma amyloid-? 1?42/1?40 a better biomarker for Alzheimer?s disease than A?X?42/X?40?
xmpMM:DocumentID: uuid:94bb6da1-65c2-40c9-8629-647fccae8196
Last-Save-Date: 2022-12-03T02:45:53Z
CrossMarkDomains[1]: springer.com
pdf:docinfo:keywords: Alzheimer?s disease; Biomarker; Amyloid-? peptides; Blood plasma; A?42/40 ratio; Immunoassay
pdf:docinfo:modified: 2022-12-03T02:45:53Z
meta:save-date: 2022-12-03T02:45:53Z
Content-Type: application/pdf
X-Parsed-By: org.apache.tika.parser.DefaultParser
creator: Barbara Morgado 
pdfaid:conformance: B
dc:language: EN
dc:subject: Alzheimer?s disease; Biomarker; Amyloid-? peptides; Blood plasma; A?42/40 ratio; Immunoassay
access_permission:assemble_document: true
xmpTPg:NPages: 14
pdf:charsPerPage: 4217
access_permission:extract_content: true
access_permission:can_print: true
CrossMarkDomains[2]: springerlink.com
meta:keyword: Alzheimer?s disease; Biomarker; Amyloid-? peptides; Blood plasma; A?42/40 ratio; Immunoassay
access_permission:can_modify: true
pdf:docinfo:created: 2022-12-02T15:14:03Z
CrossmarkMajorVersionDate: 2010-04-23